The German biotechnology market is anticipated to grow at a CAGR of 7.5% during the forecast period. The country has a strong presence of biology labs such as the Institute of Applied Microbiology, Berlin Institute of Technology, LOEWE Center for Synthetic Microbiology Marburg, and Ansbach University of Applied Sciences. In addition to this, a large number of global as well as domestic biotech companies are active in the country. Hence, the aforementioned factors are anticipated to significantly influence the market growth.
Additionally, the considerable application of biotechnology in the agriculture and animal husbandry sector of the country is also aiding to the growing market shares. The high spending on drug R&D by the country is also aiding to the growth of the market. As per the European Federation of Pharmaceutical Industries and Associations, around $8.3 billion was invested in pharmaceutical in 2017 in drug R&D in the country.
The German biotechnology market is segmented on the basis of application into bio-pharmacy, bio-services, bio-agriculture, bio-industrial, and bio-informatics. Among these, bio-pharmacy contributed a significant share. Biotechnology is driving the capabilities of personalized medicine and enables in understanding genetics and develops a platform for diagnoses, safer medication prescribing, and therapies for the diseases. In addition to human therapeutic and diagnostic applications, biotechnology has significant applications in the industry and agricultural domains. Further, the industrial uses of biotechnology involve many different sectors such as industrial enzymes, cosmetic formulations, and the diagnostics for toxicity determinations .
Some of the players operating in the German biotechnology market include Bayer AG, BioNTech SE, GlaxoSmithKline Plc, Qiagen N.V., Rentschler Biotechnologies GmbH, and others. The market players are considerably contributing to the market growth by adopting various strategies including mergers, and acquisitions, and collaborations to stay competitive in the market.
Research Methodology
The market study of the German biotechnology market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for biotechnology companies, healthcare companies, agriculture industry, end-user industries, research organizations, industry associates & experts, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions .
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints/Challenges
3.3. Opportunities
4. Market Segmentation
4.1. Germany Biotechnology Market by Application
4.1.1. Bio-Pharmacy
4.1.2. Bio-Services
4.1.3. Bio-Agriculture
4.1.4. Bio-Industries
4.1.5. Bio-Informatics
5. Company Profiles
5.1. Bayer AG
5.2. BASF SE
5.3. BIOBASE
5.4. Biomax Informatics AG
5.5. BioNTech SE
5.6. Boehringer Ingelheim
5.7. GlaxoSmithKline plc
5.8. Milltenyi Biotech GmbH
5.9. Novo Nordisk A/S
5.10. Qiagen N.V.
5.11. Rentschler Biotechnologie GmbH
1. GERMANY BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
1. GERMANY BIOTECHNOLOGY MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
2. GERMANY BIOTECHNOLOGY MARKET SIZE, 2019-2026 ($ MILLION)